Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Infection with the virus that’s the main cause of cold sores may double a person’s risk of developing dementia, according to a new study. Adding to growing evidence of a link between the two, further ...

GSK Plc (NYSE:GSK) shelved on Wednesday its herpes simplex virus (HSV) vaccine development program. The recombinant protein vaccine, dubbed GSK3943104, did not meet the study’s primary efficacy ...

Objective: The objective of this study was to provide information on the prevalence of herpes simplex infections in the general population in Europe. Goals: The goals of this study were to determine ...

The researchers found 25.6 million people aged 15 to 49 years had new HSV-2 infections and 519.5 million (13.3%) had existing (prevalent) HSV-2 infections globally in 2020. (HealthDay News) — The ...

All organisms — from fungi to mammals — have the capacity to evolve and adapt to their environments. But viruses are master shapeshifters with an ability to mutate greater than any other organism. As ...

Medical researchers found a new way genetics influences the body's antiviral response by studying a life-threatening disease caused by a common virus: herpes simplex virus 1 (HSV-1). A collaboration ...

Objectives: To evaluate the efficacy of a 1-day course of valacyclovir in reducing the duration and severity of genital herpes recurrences and to measure the frequency of viral shedding episodes ...

Herpes simplex virus (HSV) types 1 and 2 are globally prevalent viruses that establish chronic infections and cause painful ulcers during reactivation periods. Although HSV-1 primarily causes ...